Nanoparticle Drug Delivery Systems are engineered technologies that use nanoparticles for the targeted delivery and controlled release of therapeutic agents. The modern form of a drug delivery system should minimize side-effects and reduce both dosage and dosage frequency. Recently, nanoparticles have aroused attention due to their potential application for effective drug delivery.
In this report, we only study liposomal/lipid nanoparticle drug delivery system.

LNPs became more widely known in late 2020, as some COVID-19 vaccines that use RNA vaccine technology coat the fragile mRNA strands with PEGylated lipid nanoparticles as their delivery vehicle (including both the Moderna and the Pfizer?BioNTech COVID-19 vaccines).
In this report, the COVID-19 vaccines with lipid nanoparticles technologies are not covered. The COVID-19 vaccines launch on the end of 2020. We expect revenue for COVID-19 vaccines with lipid nanoparticles technologies in 2021 to be approximately 37 billion USD.
This report contains market size and forecasts of Liposomal and Lipid Nanoparticle Drug Delivery Systems in Global, including the following market information:
Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Liposomal and Lipid Nanoparticle Drug Delivery Systems market was valued at 4704.1 million in 2021 and is projected to reach US$ 8918.9 million by 2028, at a CAGR of 9.6% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Liposomes Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Liposomal and Lipid Nanoparticle Drug Delivery Systems include Johnson & Johnson, Sun Pharmaceutical, CSPC, Kinyond, Teva, Fudan-Zhangjiang, Zydus Cadila, TTY Biopharma and Pacira, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Liposomal and Lipid Nanoparticle Drug Delivery Systems companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Segment Percentages, by Type, 2021 (%)
Liposomes Drugs
Lipid Nanoparticle Drugs
Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Segment Percentages, by Application, 2021 (%)
Hospital
Retail Pharmacy
Other
Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Liposomal and Lipid Nanoparticle Drug Delivery Systems revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Liposomal and Lipid Nanoparticle Drug Delivery Systems revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Johnson & Johnson
Sun Pharmaceutical
CSPC
Kinyond
Teva
Fudan-Zhangjiang
Zydus Cadila
TTY Biopharma
Pacira
Luye Pharma
Leadiant Biosciences
Ipsen
Sayre Therapeutics
Jazz
Alnylam
Bausch Health
Acrotech Biopharma
Takeda
Chiesi Farmaceutici
Gilead Sciences

LEAVE A REPLY

Please enter your comment!
Please enter your name here